Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
10
1
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 32 publications
0
10
1
1
Order By: Relevance
“…There were no other serious adverse reactions. As a reason for the lower incidence of postvaccinal aseptic meningitis, a recent study has suggested that receiving the 1st dose of mumps vaccine at a lower age is associated with a lower risk of vaccine-associated aseptic meningitis (24).…”
Section: Discussionmentioning
confidence: 99%
“…There were no other serious adverse reactions. As a reason for the lower incidence of postvaccinal aseptic meningitis, a recent study has suggested that receiving the 1st dose of mumps vaccine at a lower age is associated with a lower risk of vaccine-associated aseptic meningitis (24).…”
Section: Discussionmentioning
confidence: 99%
“…Статистически значимое различие наблюдалось при вакцинации детей до 3 лет и детей старше 3 лет (0,078 % против 0,018 %, OR 4,35 (95 % ДИ 1,05-18,2), р = 0,04). Исследователи пришли к выводу, что снизить риск развития асептического менингита у детей возможно при условии ранней вакцинации против паротита (в возрасте до 3 лет) [33].…”
unclassified
“…One of the main reasons for not starting routine vaccination in Japan is aseptic meningitis as an adverse event of vaccination, which made the Government stop routine vaccination in 1993. The incidence of aseptic meningitis, however, could be decreased by administering the vaccine at 1 year of age . Another reason is that Japanese people tend to have much more concern about the adverse consequences of vaccination in proportion to the benefits.…”
mentioning
confidence: 99%
“…The incidence of aseptic meningitis, however, could be decreased by administering the vaccine at 1 year of age. 8 Another reason is that Japanese people tend to have much more concern about the adverse consequences of vaccination in proportion to the benefits. For example, the coverage rate of vaccines for human papilloma virus (HPV) is 1% because negative campaigns from mass media after several case reports of possible neurological adverse events made people afraid of the vaccine in Japan, even though no relationship between vaccination and neurological sequelae has been proved.…”
mentioning
confidence: 99%